Pharmacological thromboembolic prophylaxis in a medical ward: room for improvement.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 12390555.
- Also identified by PMC identifier 1495117.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate the adequacy of pharmacological thromboembolic prevention in the medical ward of a university hospital, we performed a retrospective study in 227 consecutive inpatients. The presence of risk factors, and type, length, and dose of pharmacological prevention were documented by chart review. Only 22% of the 153 risk patients received adequate prevention, whereas 38% of the patients at low risk were given pharmacological prophylaxis. The high prevalence of over- and undertreatment is an indicator of less than optimal care. Quality of care interventions, such as the development of local guidelines, might improve the appropriateness of pharmacological thromboembolic prophylaxis in medical inpatients.
Medical subject headings
- Anticoagulants
- Heparin, Low-Molecular-Weight
- Thromboembolism
- Venous Thrombosis